Coding, coverage, and payment resources for the Symplicity Spyral™ renal denervation system, used during the Symplicity™ blood pressure procedure.
Centers for Medicare & Medicaid Services (CMS) approved transitional pass-through (TPT) payment for the Symplicity™ blood pressure procedure, increasing access to care for patients with uncontrolled hypertension.
Effective January 1, 2025
We are dedicated to establishing reimbursement for the Symplicity Spyral™ system used during the Symplicity™ procedure. The following coding, coverage, and payment resources are available to guide providers through the reimbursement process, including prior authorization and appeals.
If you have hypertension, or care for someone who does, and are interested in learning more about the Symplicity™ procedure, visit the patient page.
Fill out a short form so our reimbursement team can email the following resources to you directly.
To facilitate patient access, our dedicated team can assist with education on and submission of prior authorizations and appeals for the Symplicity™ procedure. If you are a healthcare provider and would like additional information or assistance, contact your regional economic manager (REM) or email the patient access support team.
If you can‘t find what you‘re looking for or just need to get in touch with our team, send us an email.
Subscribe to receive email about the Symplicity™ procedure and Symplicity Spyral™ system.
Medtronic provides this information for your convenience only. It does not constitute legal advice or a recommendation regarding clinical practice. Information provided is gathered from third-party sources and is subject to change without notice due to frequently changing laws, rules, and regulations. The provider has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided.
Medtronic makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other payers as to the correct form of billing or the amount that will be paid to providers of service. Please contact your Medicare contractor, other payers, reimbursement specialists and/or legal counsel for interpretation of coding, coverage, and payment policies.
These resources provide assistance for FDA approved or cleared indications. Where reimbursement is sought for use of a product that may be inconsistent with, or not expressly specified in, the FDA cleared or approved labeling (e.g., instructions for use, operator’s manual, or package insert), consult with your billing advisors or payers on handling such billing issues. Some payers may have policies that make it inappropriate to submit claims for such items or related service.
If you have questions regarding reimbursement for the Symplicity™ procedure, including the Symplicity Spyral™ RDN system, contact our customer support team.
